U.S. Markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
136.25-7.13 (-4.97%)
At close: 04:00PM EDT
136.00 -0.25 (-0.18%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close143.38
Bid135.45 x 1100
Ask136.00 x 1000
Day's Range131.39 - 144.77
52 Week Range119.01 - 497.49
Avg. Volume7,157,155
Market Cap55.243B
Beta (5Y Monthly)1.54
PE Ratio (TTM)8.16
EPS (TTM)16.69
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est230.27
  • Motley Fool

    3 Stocks That Could Make You a Fortune Over the Next 10 Years

    Here's why they picked Exelixis (NASDAQ: EXEL), Moderna (NASDAQ: MRNA), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Exelixis): If you're looking to hit a home run with an investment, it's important to look for a balance of a modest valuation and promising growth. One underrated stock that possesses all these features is cancer-fighting company Exelixis, which has a market cap of around $5.4 billion.

  • Motley Fool

    Better Buy: Moderna or Novavax?

    Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) are no longer big winners for investors. Let's first address the uncertainties for Moderna. There are questions about the high number of side effects of its experimental influenza vaccine.

  • Motley Fool

    Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding

    Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.